世界のペイロニー病治療市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Peyronie’s Disease Treatment Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-4696
• 出版社/出版日：QYResearch / 2021年6月
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、89ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医療

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Multi User	￥865,800 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査レポートでは、ペイロニー病治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（治療薬、手術）、用途別市場規模（病院、ドラッグストア）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。
・市場概要
・ペイロニー病治療の市場動向
・企業の競争状況、市場シェア
・ペイロニー病治療の種類別市場規模と予測2016-2027（治療薬、手術）
・ペイロニー病治療の用途別市場規模と予測2016-2027（病院、ドラッグストア）
・ペイロニー病治療の北米市場規模2016-2027（アメリカ、カナダ）
・ペイロニー病治療の欧州市場規模2016-2027（ドイツ、フランス、イギリス等）
・ペイロニー病治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・ペイロニー病治療の中南米市場規模2016-2027（メキシコ、ブラジル）
・ペイロニー病治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（Endo International、Asahi Kasei、BioSpecifics Technologies）
・結論

Peyronie’s disease (PD) is condition wherein the penis is curved or bent due to development of plaque or a fibrous scar tissue inside the penis.

Market Analysis and Insights: Global Peyronie’s Disease Treatment Market
The global Peyronie’s Disease Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Peyronie’s Disease Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Peyronie’s Disease Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Peyronie’s Disease Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Peyronie’s Disease Treatment market.

Global Peyronie’s Disease Treatment Scope and Market Size
Peyronie’s Disease Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Peyronie’s Disease Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Drugs
Surgery

Segment by Application
Hospital
Drugs Store

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Endo International
Asahi Kasei
BioSpecifics Technologies

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Peyronie’s Disease Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Drugs
1.2.3 Surgery
1.3 Market by Application
1.3.1 Global Peyronie’s Disease Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital
1.3.3 Drugs Store
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Peyronie’s Disease Treatment Market Perspective (2016-2027)
2.2 Peyronie’s Disease Treatment Growth Trends by Regions
2.2.1 Peyronie’s Disease Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Peyronie’s Disease Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Peyronie’s Disease Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Peyronie’s Disease Treatment Industry Dynamic
2.3.1 Peyronie’s Disease Treatment Market Trends
2.3.2 Peyronie’s Disease Treatment Market Drivers
2.3.3 Peyronie’s Disease Treatment Market Challenges
2.3.4 Peyronie’s Disease Treatment Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Peyronie’s Disease Treatment Players by Revenue
3.1.1 Global Top Peyronie’s Disease Treatment Players by Revenue (2016-2021)
3.1.2 Global Peyronie’s Disease Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Peyronie’s Disease Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Peyronie’s Disease Treatment Revenue
3.4 Global Peyronie’s Disease Treatment Market Concentration Ratio
3.4.1 Global Peyronie’s Disease Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Peyronie’s Disease Treatment Revenue in 2020
3.5 Peyronie’s Disease Treatment Key Players Head office and Area Served
3.6 Key Players Peyronie’s Disease Treatment Product Solution and Service
3.7 Date of Enter into Peyronie’s Disease Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Peyronie’s Disease Treatment Breakdown Data by Type
4.1 Global Peyronie’s Disease Treatment Historic Market Size by Type (2016-2021)
4.2 Global Peyronie’s Disease Treatment Forecasted Market Size by Type (2022-2027)

5 Peyronie’s Disease Treatment Breakdown Data by Application
5.1 Global Peyronie’s Disease Treatment Historic Market Size by Application (2016-2021)
5.2 Global Peyronie’s Disease Treatment Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Peyronie’s Disease Treatment Market Size (2016-2027)
6.2 North America Peyronie’s Disease Treatment Market Size by Type
6.2.1 North America Peyronie’s Disease Treatment Market Size by Type (2016-2021)
6.2.2 North America Peyronie’s Disease Treatment Market Size by Type (2022-2027)
6.2.3 North America Peyronie’s Disease Treatment Market Size by Type (2016-2027)
6.3 North America Peyronie’s Disease Treatment Market Size by Application
6.3.1 North America Peyronie’s Disease Treatment Market Size by Application (2016-2021)
6.3.2 North America Peyronie’s Disease Treatment Market Size by Application (2022-2027)
6.3.3 North America Peyronie’s Disease Treatment Market Size by Application (2016-2027)
6.4 North America Peyronie’s Disease Treatment Market Size by Country
6.4.1 North America Peyronie’s Disease Treatment Market Size by Country (2016-2021)
6.4.2 North America Peyronie’s Disease Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Peyronie’s Disease Treatment Market Size (2016-2027)
7.2 Europe Peyronie’s Disease Treatment Market Size by Type
7.2.1 Europe Peyronie’s Disease Treatment Market Size by Type (2016-2021)
7.2.2 Europe Peyronie’s Disease Treatment Market Size by Type (2022-2027)
7.2.3 Europe Peyronie’s Disease Treatment Market Size by Type (2016-2027)
7.3 Europe Peyronie’s Disease Treatment Market Size by Application
7.3.1 Europe Peyronie’s Disease Treatment Market Size by Application (2016-2021)
7.3.2 Europe Peyronie’s Disease Treatment Market Size by Application (2022-2027)
7.3.3 Europe Peyronie’s Disease Treatment Market Size by Application (2016-2027)
7.4 Europe Peyronie’s Disease Treatment Market Size by Country
7.4.1 Europe Peyronie’s Disease Treatment Market Size by Country (2016-2021)
7.4.2 Europe Peyronie’s Disease Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Peyronie’s Disease Treatment Market Size (2016-2027)
8.2 Asia-Pacific Peyronie’s Disease Treatment Market Size by Type
8.2.1 Asia-Pacific Peyronie’s Disease Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Peyronie’s Disease Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Peyronie’s Disease Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Peyronie’s Disease Treatment Market Size by Application
8.3.1 Asia-Pacific Peyronie’s Disease Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Peyronie’s Disease Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Peyronie’s Disease Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Peyronie’s Disease Treatment Market Size by Region
8.4.1 Asia-Pacific Peyronie’s Disease Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Peyronie’s Disease Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Peyronie’s Disease Treatment Market Size (2016-2027)
9.2 Latin America Peyronie’s Disease Treatment Market Size by Type
9.2.1 Latin America Peyronie’s Disease Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Peyronie’s Disease Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Peyronie’s Disease Treatment Market Size by Type (2016-2027)
9.3 Latin America Peyronie’s Disease Treatment Market Size by Application
9.3.1 Latin America Peyronie’s Disease Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Peyronie’s Disease Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Peyronie’s Disease Treatment Market Size by Application (2016-2027)
9.4 Latin America Peyronie’s Disease Treatment Market Size by Country
9.4.1 Latin America Peyronie’s Disease Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Peyronie’s Disease Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Peyronie’s Disease Treatment Market Size (2016-2027)
10.2 Middle East & Africa Peyronie’s Disease Treatment Market Size by Type
10.2.1 Middle East & Africa Peyronie’s Disease Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Peyronie’s Disease Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Peyronie’s Disease Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Peyronie’s Disease Treatment Market Size by Application
10.3.1 Middle East & Africa Peyronie’s Disease Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Peyronie’s Disease Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Peyronie’s Disease Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Peyronie’s Disease Treatment Market Size by Country
10.4.1 Middle East & Africa Peyronie’s Disease Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Peyronie’s Disease Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Endo International
11.1.1 Endo International Company Details
11.1.2 Endo International Business Overview
11.1.3 Endo International Peyronie’s Disease Treatment Introduction
11.1.4 Endo International Revenue in Peyronie’s Disease Treatment Business (2016-2021)
11.1.5 Endo International Recent Development
11.2 Asahi Kasei
11.2.1 Asahi Kasei Company Details
11.2.2 Asahi Kasei Business Overview
11.2.3 Asahi Kasei Peyronie’s Disease Treatment Introduction
11.2.4 Asahi Kasei Revenue in Peyronie’s Disease Treatment Business (2016-2021)
11.2.5 Asahi Kasei Recent Development
11.3 BioSpecifics Technologies
11.3.1 BioSpecifics Technologies Company Details
11.3.2 BioSpecifics Technologies Business Overview
11.3.3 BioSpecifics Technologies Peyronie’s Disease Treatment Introduction
11.3.4 BioSpecifics Technologies Revenue in Peyronie’s Disease Treatment Business (2016-2021)
11.3.5 BioSpecifics Technologies Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Peyronie’s Disease Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Drugs
Table 3. Key Players of Surgery
Table 4. Global Peyronie’s Disease Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Peyronie’s Disease Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Peyronie’s Disease Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Peyronie’s Disease Treatment Market Share by Regions (2016-2021)
Table 8. Global Peyronie’s Disease Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Peyronie’s Disease Treatment Market Share by Regions (2022-2027)
Table 10. Peyronie’s Disease Treatment Market Trends
Table 11. Peyronie’s Disease Treatment Market Drivers
Table 12. Peyronie’s Disease Treatment Market Challenges
Table 13. Peyronie’s Disease Treatment Market Restraints
Table 14. Global Peyronie’s Disease Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Peyronie’s Disease Treatment Market Share by Players (2016-2021)
Table 16. Global Top Peyronie’s Disease Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Peyronie’s Disease Treatment as of 2020)
Table 17. Ranking of Global Top Peyronie’s Disease Treatment Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Peyronie’s Disease Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Peyronie’s Disease Treatment Product Solution and Service
Table 21. Date of Enter into Peyronie’s Disease Treatment Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Peyronie’s Disease Treatment Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Peyronie’s Disease Treatment Revenue Market Share by Type (2016-2021)
Table 25. Global Peyronie’s Disease Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Peyronie’s Disease Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Peyronie’s Disease Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Peyronie’s Disease Treatment Revenue Market Share by Application (2016-2021)
Table 29. Global Peyronie’s Disease Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Peyronie’s Disease Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Peyronie’s Disease Treatment Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Peyronie’s Disease Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Peyronie’s Disease Treatment Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Peyronie’s Disease Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Peyronie’s Disease Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Peyronie’s Disease Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Peyronie’s Disease Treatment Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Peyronie’s Disease Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Peyronie’s Disease Treatment Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Peyronie’s Disease Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Peyronie’s Disease Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Peyronie’s Disease Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Peyronie’s Disease Treatment Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Peyronie’s Disease Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Peyronie’s Disease Treatment Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Peyronie’s Disease Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Peyronie’s Disease Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Peyronie’s Disease Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Peyronie’s Disease Treatment Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Peyronie’s Disease Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Peyronie’s Disease Treatment Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Peyronie’s Disease Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Peyronie’s Disease Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Peyronie’s Disease Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Peyronie’s Disease Treatment Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Peyronie’s Disease Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Peyronie’s Disease Treatment Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Peyronie’s Disease Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Peyronie’s Disease Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Peyronie’s Disease Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 61. Endo International Company Details
Table 62. Endo International Business Overview
Table 63. Endo International Peyronie’s Disease Treatment Product
Table 64. Endo International Revenue in Peyronie’s Disease Treatment Business (2016-2021) & (US$ Million)
Table 65. Endo International Recent Development
Table 66. Asahi Kasei Company Details
Table 67. Asahi Kasei Business Overview
Table 68. Asahi Kasei Peyronie’s Disease Treatment Product
Table 69. Asahi Kasei Revenue in Peyronie’s Disease Treatment Business (2016-2021) & (US$ Million)
Table 70. Asahi Kasei Recent Development
Table 71. BioSpecifics Technologies Company Details
Table 72. BioSpecifics Technologies Business Overview
Table 73. BioSpecifics Technologies Peyronie’s Disease Treatment Product
Table 74. BioSpecifics Technologies Revenue in Peyronie’s Disease Treatment Business (2016-2021) & (US$ Million)
Table 75. BioSpecifics Technologies Recent Development
Table 76. Research Programs/Design for This Report
Table 77. Key Data Information from Secondary Sources
Table 78. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Peyronie’s Disease Treatment Market Share by Type: 2020 VS 2027
Figure 2. Drugs Features
Figure 3. Surgery Features
Figure 4. Global Peyronie’s Disease Treatment Market Share by Application: 2020 VS 2027
Figure 5. Hospital Case Studies
Figure 6. Drugs Store Case Studies
Figure 7. Peyronie’s Disease Treatment Report Years Considered
Figure 8. Global Peyronie’s Disease Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 9. Global Peyronie’s Disease Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 10. Global Peyronie’s Disease Treatment Market Share by Regions: 2020 VS 2027
Figure 11. Global Peyronie’s Disease Treatment Market Share by Regions (2022-2027)
Figure 12. Global Peyronie’s Disease Treatment Market Share by Players in 2020
Figure 13. Global Top Peyronie’s Disease Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Peyronie’s Disease Treatment as of 2020
Figure 14. The Top 10 and 5 Players Market Share by Peyronie’s Disease Treatment Revenue in 2020
Figure 15. Global Peyronie’s Disease Treatment Revenue Market Share by Type (2016-2021)
Figure 16. Global Peyronie’s Disease Treatment Revenue Market Share by Type (2022-2027)
Figure 17. North America Peyronie’s Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 18. North America Peyronie’s Disease Treatment Market Share by Type (2016-2027)
Figure 19. North America Peyronie’s Disease Treatment Market Share by Application (2016-2027)
Figure 20. North America Peyronie’s Disease Treatment Market Share by Country (2016-2027)
Figure 21. United States Peyronie’s Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. Canada Peyronie’s Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Europe Peyronie’s Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Peyronie’s Disease Treatment Market Share by Type (2016-2027)
Figure 25. Europe Peyronie’s Disease Treatment Market Share by Application (2016-2027)
Figure 26. Europe Peyronie’s Disease Treatment Market Share by Country (2016-2027)
Figure 27. Germany Peyronie’s Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. France Peyronie’s Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. U.K. Peyronie’s Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. Italy Peyronie’s Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Russia Peyronie’s Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Nordic Peyronie’s Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Asia-Pacific Peyronie’s Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Peyronie’s Disease Treatment Market Share by Type (2016-2027)
Figure 35. Asia-Pacific Peyronie’s Disease Treatment Market Share by Application (2016-2027)
Figure 36. Asia-Pacific Peyronie’s Disease Treatment Market Share by Region (2016-2027)
Figure 37. China Peyronie’s Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Japan Peyronie’s Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. South Korea Peyronie’s Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Southeast Asia Peyronie’s Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. India Peyronie’s Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Australia Peyronie’s Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Latin America Peyronie’s Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Peyronie’s Disease Treatment Market Share by Type (2016-2027)
Figure 45. Latin America Peyronie’s Disease Treatment Market Share by Application (2016-2027)
Figure 46. Latin America Peyronie’s Disease Treatment Market Share by Country (2016-2027)
Figure 47. Mexico Peyronie’s Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Brazil Peyronie’s Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Middle East & Africa Peyronie’s Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Peyronie’s Disease Treatment Market Share by Type (2016-2027)
Figure 51. Middle East & Africa Peyronie’s Disease Treatment Market Share by Application (2016-2027)
Figure 52. Middle East & Africa Peyronie’s Disease Treatment Market Share by Country (2016-2027)
Figure 53. Turkey Peyronie’s Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Saudi Arabia Peyronie’s Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. UAE Peyronie’s Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Endo International Revenue Growth Rate in Peyronie’s Disease Treatment Business (2016-2021)
Figure 57. Asahi Kasei Revenue Growth Rate in Peyronie’s Disease Treatment Business (2016-2021)
Figure 58. BioSpecifics Technologies Revenue Growth Rate in Peyronie’s Disease Treatment Business (2016-2021)
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed

Global Von Willebrand Disease Treatment Market Size, Status and Forecast 2021-2027
QFJ1-5033 2021年6月 100Pages
QYResearch社発行の本調査レポートでは、フォン・ヴィレブランド病治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（Veyvondi、Humate-P、Alphanate、その他）、用途別市場規模（病院、診療所、その他）、主要地域別市場規模...

世界のバッテン病治療市場規模・現状・予測（2021年-2027年）

Global Batten Disease Treatment Market Size, Status and Forecast 2021-2027
QFJ1-3891 2021年6月 96Pages
QYResearch社発行の本調査レポートでは、バッテン病治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（作業療法、理学療法）、用途別市場規模（乳児NCL、後期乳児NCL、少年NCL、成人NCL）、主要地域別市場規模（北米、アメリカ、欧州、アジ...

世界の多発性嚢胞腎治療薬市場規模・現状・予測（2021年-2027年）

Global Polycystic Kidney Disease Treatment Drugs Market Size, Status and Forecast 2021-2027
QFJ1-4730 2021年6月 99Pages
QYResearch社発行の本調査レポートでは、多発性嚢胞腎治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（ANG-3070、CIM-2、CR-8、その他）、用途別市場規模（常染色体優性多発性嚢胞腎（ADPKD）、常染色体劣性多発性嚢胞腎（A...

世界のアジソン病用治療市場規模・現状・予測（2021年-2027年）

Global Addison's Disease Treatment Market Size, Status and Forecast 2021-2027
QFJ1-3763 2021年6月 98Pages
QYResearch社発行の本調査レポートでは、アジソン病用治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（経口コルチコステロイド、コルチコステロイド注射）、用途別市場規模（病院、診療所、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジ...

世界のリソソーム蓄積症治療市場規模・現状・予測（2021年-2027年）

Global Lysosomal Storage Disease Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4451 2021年6月 95Pages
QYResearch社発行の本調査レポートでは、リソソーム蓄積症治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（酵素補充療法、幹細胞移植、基質減少療法、その他）、用途別市場規模（病院、クリニック、幹細胞移植センター、研究機関、その他）、主要地域...

世界のICAD (頭蓋内アテローム性動脈硬化症) 病理学治療市場規模・現状・予測（2021年-2027年）

Global ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Size, Status and Forecast 2021-2027
QFJ1-5203 2021年6月 98Pages
QYResearch社発行の本調査レポートでは、ICAD (頭蓋内アテローム性動脈硬化症) 病理学治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（ステント、PTAバルーン）、用途別市場規模（病院、診療所、その他）、主要地域別市場規模（北米、アメ...

世界の認知症＆アルツハイマー病治療市場規模・現状・予測（2021年-2027年）

Global Dementia and Alzheimer’s Disease Treatment Market Size, Status and Forecast 2021-2027
QFJ1-5693 2021年6月 108Pages
QYResearch社発行の本調査レポートでは、認知症＆アルツハイマー病治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（コリンエステラーゼ阻害剤、メマンチン、併用薬）、用途別市場規模（病院、診療所）、主要地域別市場規模（北米、アメリカ、欧州、ア...

世界のパジェット病治療市場規模・現状・予測（2021年-2027年）

Global Paget's Disease Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4647 2021年6月 100Pages
QYResearch社発行の本調査レポートでは、パジェット病治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（ビスフォスフォネート、カルシトニン類似体（サーモンカルシトニン）、鎮痛剤、カルシウム・ビタミンDサプリメント）、用途別市場規模（病院、ク...

世界のエルドハイムチェスター病治療法市場規模・現状・予測（2021年-2027年）

Global Erdheim Chester Disease Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4203 2021年6月 96Pages
QYResearch社発行の本調査レポートでは、エルドハイムチェスター病治療法の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（免疫療法、化学療法）、用途別市場規模（病院、診療所、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国...

世界の肺・気道疾患治療市場規模・現状・予測（2021年-2027年）

Global Lung Pulmonary Airway Disease Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4446 2021年6月 99Pages
QYResearch社発行の本調査レポートでは、肺・気道疾患治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（気管支拡張薬、細胞毒性薬、抗生物質、その他）、用途別市場規模（病院、クリニック、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジ...

世界の多発性嚢胞腎治療薬市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Polycystic Kidney Disease Treatment Drugs Market The global Polycystic Kidney Disease Treatment Drugs market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in anal…
世界の後天性嚢胞性腎疾患治療薬市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Acquired Cystic Kidney Disease Treatment Drugs Market The global Acquired Cystic Kidney Disease Treatment Drugs market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accura…
世界のフォン・ヴィレブランド病治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Von Willebrand Disease Treatment Market The global Von Willebrand Disease Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data…
世界の認知症＆アルツハイマー病治療市場規模・現状・予測（2021年-2027年） Alzheimer’s disease is a chronic neurodegenerative disorder which results in gradual degradation of the tissues of the brain. This hampers the normal functioning of the brain and impacts the daily lives of patients. Market Analysis and Insights: Global Dementia and Alzheimer’s Disease Treatment Mark…
世界のバッテン病治療市場規模・現状・予測（2021年-2027年） Batten disease is inherited disorder of the nervous system which begins in childhood.It is also called as neuronal ceroid lipofuscinoses (or NCLs). Batten Disease Treatment is the treatment of this type of disease. Market Analysis and Insights: Global Batten Disease Treatment Market The global Batte…